Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Courtesy of Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University. The first intelligent clinical research ward dedicated to brain-computer interface ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

InBrain Neuroelectronics announced today that it entered into a strategic collaboration with Microsoft to explore AI in ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...